Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Kiser

Concepts (362)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
34
2026
767
6.120
 Why?
Hepatitis C
15
2026
254
4.360
 Why?
Anti-HIV Agents
35
2025
888
4.010
 Why?
Hepatitis C, Chronic
15
2026
152
4.010
 Why?
HIV Infections
56
2025
3154
3.880
 Why?
Adenine
30
2025
339
3.830
 Why?
Sofosbuvir
14
2026
61
3.750
 Why?
Ribavirin
15
2020
80
3.630
 Why?
Drug Interactions
21
2019
398
3.130
 Why?
Tenofovir
31
2025
295
3.020
 Why?
Tandem Mass Spectrometry
17
2025
576
2.150
 Why?
Hepacivirus
13
2026
243
1.970
 Why?
Proline
6
2026
83
1.810
 Why?
Dried Blood Spot Testing
13
2024
126
1.740
 Why?
Oligopeptides
8
2015
269
1.680
 Why?
Organophosphates
16
2025
187
1.650
 Why?
Emtricitabine
19
2025
205
1.620
 Why?
Organophosphonates
12
2014
97
1.480
 Why?
Benzimidazoles
8
2026
190
1.410
 Why?
Ritonavir
8
2021
75
1.370
 Why?
Protease Inhibitors
4
2020
102
1.330
 Why?
Chromatography, Liquid
14
2025
454
1.230
 Why?
Coinfection
5
2024
141
1.210
 Why?
Phosphorous Acids
3
2019
15
1.130
 Why?
Fluorenes
4
2020
46
1.030
 Why?
Pyrophosphatases
3
2016
25
1.010
 Why?
Hepatitis B
4
2024
66
1.000
 Why?
Nucleotides
3
2016
128
1.000
 Why?
Drug Monitoring
8
2024
395
0.930
 Why?
Anti-Retroviral Agents
5
2019
250
0.880
 Why?
Drug Therapy, Combination
12
2018
1047
0.820
 Why?
Sulfonamides
6
2026
580
0.820
 Why?
Pyridines
5
2015
605
0.750
 Why?
Polyphosphates
7
2022
45
0.730
 Why?
Humans
104
2026
144759
0.720
 Why?
Cell Phone
1
2022
82
0.710
 Why?
Reverse Transcriptase Inhibitors
5
2014
87
0.700
 Why?
Erythrocytes
8
2016
757
0.700
 Why?
HIV Protease Inhibitors
5
2011
69
0.700
 Why?
Carbamates
3
2026
52
0.690
 Why?
Membrane Transport Proteins
4
2016
154
0.680
 Why?
Simeprevir
2
2018
5
0.680
 Why?
Viral Load
11
2024
526
0.660
 Why?
Isoniazid
3
2026
71
0.660
 Why?
HIV-1
7
2021
896
0.660
 Why?
Mobile Applications
1
2022
196
0.620
 Why?
Therapies, Investigational
1
2019
18
0.610
 Why?
Antitubercular Agents
3
2026
215
0.590
 Why?
Heterocyclic Compounds, 3-Ring
2
2023
44
0.580
 Why?
Medication Adherence
12
2022
539
0.580
 Why?
Respiratory Syncytial Virus Infections
1
2020
136
0.570
 Why?
Leukocytes, Mononuclear
9
2025
573
0.560
 Why?
Adult
47
2026
40449
0.560
 Why?
Ethanol
1
2023
627
0.550
 Why?
Male
57
2026
72315
0.540
 Why?
Pyridazines
2
2021
57
0.540
 Why?
Antiretroviral Therapy, Highly Active
4
2015
278
0.540
 Why?
Middle Aged
40
2026
35875
0.520
 Why?
Solid Phase Extraction
2
2014
25
0.520
 Why?
Lung Transplantation
1
2020
338
0.510
 Why?
Pyrimidinones
2
2008
126
0.500
 Why?
HIV Integrase Inhibitors
1
2018
78
0.500
 Why?
Inosine
1
2016
14
0.500
 Why?
Liver
2
2016
1887
0.490
 Why?
Guanosine
1
2016
40
0.490
 Why?
Tuberculosis
3
2026
291
0.490
 Why?
Pharmacogenomic Variants
1
2016
33
0.490
 Why?
Heterocyclic Compounds, 4 or More Rings
2
2026
23
0.470
 Why?
Female
53
2026
78271
0.460
 Why?
Purines
1
2016
187
0.460
 Why?
Chromatography, High Pressure Liquid
2
2015
594
0.450
 Why?
Drug Discovery
1
2016
155
0.450
 Why?
Serum
1
2015
58
0.440
 Why?
Adenosine
1
2016
255
0.430
 Why?
Intracellular Space
1
2014
66
0.430
 Why?
Kidney
4
2016
1495
0.420
 Why?
HIV
4
2019
250
0.410
 Why?
Priapism
1
2013
10
0.410
 Why?
Receptors, Adrenergic, alpha
1
2013
19
0.410
 Why?
Adrenergic alpha-Antagonists
1
2013
34
0.400
 Why?
Pre-Exposure Prophylaxis
5
2020
246
0.400
 Why?
Cytochrome P-450 CYP3A Inhibitors
1
2013
18
0.400
 Why?
Deoxycytidine
6
2017
221
0.390
 Why?
Treatment Outcome
15
2026
11679
0.390
 Why?
Telemedicine
1
2022
945
0.390
 Why?
Quinoxalines
2
2026
65
0.380
 Why?
Hepatitis B, Chronic
3
2022
22
0.370
 Why?
Hepatitis B virus
4
2024
33
0.370
 Why?
Genotype
7
2026
1833
0.370
 Why?
Gastric Bypass
1
2014
125
0.360
 Why?
Pyrrolidines
2
2026
125
0.360
 Why?
Area Under Curve
5
2026
330
0.350
 Why?
Phenotype
2
2016
3162
0.340
 Why?
Alanine
5
2025
171
0.330
 Why?
HIV Seronegativity
1
2010
29
0.330
 Why?
Antacids
1
2010
16
0.330
 Why?
Pyrrolidinones
1
2010
29
0.330
 Why?
Prospective Studies
17
2022
7990
0.330
 Why?
Pyrimidines
3
2021
532
0.310
 Why?
Patient Compliance
3
2017
588
0.310
 Why?
Pharmacy Service, Hospital
1
2011
81
0.310
 Why?
Blood Chemical Analysis
4
2019
109
0.300
 Why?
Plasma
4
2016
225
0.300
 Why?
Pregnancy Complications, Infectious
3
2025
428
0.290
 Why?
Reproducibility of Results
8
2016
3409
0.290
 Why?
Uridine Monophosphate
2
2019
16
0.290
 Why?
Sustained Virologic Response
4
2026
46
0.290
 Why?
Drug Prescriptions
1
2011
284
0.280
 Why?
Fluorobenzenes
1
2008
17
0.280
 Why?
Adolescent
21
2026
22428
0.280
 Why?
Drug Stability
5
2016
164
0.270
 Why?
Young Adult
17
2025
14105
0.270
 Why?
Guidelines as Topic
1
2009
267
0.260
 Why?
Liver Transplantation
1
2014
823
0.260
 Why?
Atazanavir Sulfate
5
2015
42
0.250
 Why?
Sensitivity and Specificity
5
2014
1985
0.250
 Why?
Half-Life
3
2015
151
0.250
 Why?
Anti-Ulcer Agents
1
2006
12
0.240
 Why?
Esomeprazole
1
2006
7
0.240
 Why?
Glycerophospholipids
2
2023
39
0.240
 Why?
Pharmacology, Clinical
1
2006
9
0.240
 Why?
Cyclopropanes
3
2026
83
0.230
 Why?
Hepatocytes
3
2016
223
0.230
 Why?
Education
1
2006
104
0.230
 Why?
Proton Pump Inhibitors
1
2006
109
0.220
 Why?
Aminoisobutyric Acids
2
2026
9
0.220
 Why?
South Africa
4
2015
261
0.210
 Why?
Phosphates
3
2015
180
0.210
 Why?
Milk, Human
1
2026
172
0.210
 Why?
Lactams, Macrocyclic
2
2026
51
0.210
 Why?
Anemia
2
2016
188
0.200
 Why?
Leucine
2
2026
116
0.200
 Why?
Biomarkers
5
2023
4271
0.200
 Why?
Variola virus
1
2022
3
0.190
 Why?
Smallpox
1
2022
10
0.190
 Why?
Health Personnel
1
2009
748
0.190
 Why?
World Health Organization
1
2022
105
0.190
 Why?
Delivery of Health Care
1
2009
947
0.180
 Why?
Linear Models
2
2014
854
0.180
 Why?
Drug Combinations
4
2026
390
0.180
 Why?
Cross-Over Studies
4
2020
601
0.170
 Why?
Lopinavir
3
2020
30
0.170
 Why?
Blood Platelets
1
2025
400
0.170
 Why?
Dideoxynucleosides
2
2023
22
0.170
 Why?
Point-of-Care Systems
1
2023
187
0.160
 Why?
Phosphorylation
2
2015
1732
0.160
 Why?
Interferons
2
2019
188
0.160
 Why?
Drug Administration Schedule
3
2019
779
0.160
 Why?
Neutrophils
1
2025
1134
0.150
 Why?
Arylamine N-Acetyltransferase
2
2026
8
0.150
 Why?
Homosexuality, Male
2
2017
222
0.150
 Why?
Nucleic Acids
1
2019
72
0.140
 Why?
Quality Control
2
2015
163
0.140
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.140
 Why?
Oxazines
1
2018
37
0.130
 Why?
Directly Observed Therapy
1
2017
15
0.130
 Why?
Bronchoalveolar Lavage Fluid
1
2020
636
0.130
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2017
19
0.130
 Why?
Liver Cirrhosis
1
2019
288
0.130
 Why?
Pharmacogenetics
2
2016
172
0.130
 Why?
Inosine Triphosphate
1
2016
2
0.130
 Why?
Anemia, Hemolytic
1
2016
16
0.130
 Why?
Nitriles
2
2021
205
0.130
 Why?
Darunavir
2
2014
20
0.130
 Why?
Deoxyadenine Nucleotides
1
2016
15
0.130
 Why?
Deoxycytosine Nucleotides
1
2016
13
0.130
 Why?
Guanosine Triphosphate
1
2016
89
0.120
 Why?
Glass
1
2016
46
0.120
 Why?
Molecular Targeted Therapy
1
2019
432
0.120
 Why?
Pharmacy
1
2017
33
0.120
 Why?
Pregnancy Outcome
1
2020
476
0.120
 Why?
Genitalia
1
2016
34
0.120
 Why?
Drug Packaging
1
2016
41
0.120
 Why?
Disease Transmission, Infectious
1
2017
69
0.120
 Why?
Syringes
1
2016
49
0.120
 Why?
Drug and Narcotic Control
1
2016
24
0.120
 Why?
Furans
2
2026
27
0.120
 Why?
Infant
6
2026
10034
0.120
 Why?
Zika Virus
1
2017
132
0.120
 Why?
Viremia
3
2022
158
0.120
 Why?
Pyridones
1
2018
199
0.120
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2011
439
0.120
 Why?
Benzopyrans
2
2026
30
0.120
 Why?
Fibroblast Growth Factors
2
2014
188
0.120
 Why?
Polymers
1
2019
499
0.120
 Why?
Polymorphism, Single Nucleotide
2
2016
2145
0.110
 Why?
Biological Assay
1
2016
128
0.110
 Why?
Cytosol
1
2016
227
0.110
 Why?
Practice Guidelines as Topic
2
2016
1560
0.110
 Why?
Creatinine
2
2018
506
0.110
 Why?
Rectum
1
2016
180
0.110
 Why?
Population
1
2015
30
0.110
 Why?
Piperazines
1
2018
381
0.110
 Why?
Brain Diseases
1
2016
152
0.110
 Why?
Analgesics
1
2017
228
0.110
 Why?
Nonlinear Dynamics
1
2015
95
0.110
 Why?
Liver Function Tests
1
2015
106
0.110
 Why?
Chemical and Drug Induced Liver Injury
1
2016
139
0.110
 Why?
Retrospective Studies
4
2020
17066
0.110
 Why?
CD4 Lymphocyte Count
2
2015
277
0.110
 Why?
Pharmaceutical Preparations
1
2016
170
0.110
 Why?
Virus Replication
1
2017
529
0.110
 Why?
Pharmacists
1
2017
240
0.100
 Why?
Least-Squares Analysis
1
2014
76
0.100
 Why?
Mental Health Services
1
2019
473
0.100
 Why?
Child, Preschool
5
2026
11787
0.100
 Why?
Adenosine Triphosphate
1
2016
498
0.100
 Why?
Infectious Disease Transmission, Vertical
3
2025
193
0.100
 Why?
Administration, Oral
3
2019
847
0.100
 Why?
Metabolic Clearance Rate
2
2018
114
0.100
 Why?
Hypophosphatemia
1
2013
17
0.100
 Why?
Cholecalciferol
1
2014
60
0.100
 Why?
Diphosphates
3
2021
20
0.100
 Why?
Calcitriol
1
2013
58
0.100
 Why?
Double-Blind Method
3
2013
2029
0.100
 Why?
Liver Diseases
1
2016
304
0.100
 Why?
Tablets
2
2023
41
0.100
 Why?
Cytochrome P-450 CYP3A
1
2013
93
0.100
 Why?
Leukocytes
1
2014
295
0.090
 Why?
Desiccation
1
2012
24
0.090
 Why?
Monocytes
1
2015
538
0.090
 Why?
Case-Control Studies
3
2024
3604
0.090
 Why?
Benzoxazines
1
2012
31
0.090
 Why?
Kidney Diseases
1
2016
427
0.090
 Why?
Organic Anion Transporters
1
2011
13
0.090
 Why?
Levonorgestrel
1
2012
35
0.090
 Why?
Diabetes Mellitus
1
2020
1098
0.090
 Why?
Pravastatin
1
2011
43
0.090
 Why?
Interferon-alpha
1
2012
197
0.090
 Why?
Benchmarking
2
2024
188
0.090
 Why?
Nucleosides
1
2011
25
0.090
 Why?
Vitamin D Deficiency
1
2013
186
0.090
 Why?
Contraceptive Agents, Female
1
2012
80
0.080
 Why?
Specimen Handling
1
2012
186
0.080
 Why?
Raltegravir Potassium
1
2010
18
0.080
 Why?
Hospitals, University
1
2011
176
0.080
 Why?
Body Weight
1
2015
976
0.080
 Why?
Models, Statistical
1
2015
681
0.080
 Why?
Mental Disorders
1
2019
1168
0.080
 Why?
Sex Distribution
1
2011
386
0.080
 Why?
Patient Acceptance of Health Care
1
2017
885
0.080
 Why?
Dietary Supplements
1
2014
576
0.080
 Why?
Cohort Studies
2
2019
5960
0.080
 Why?
Sex Characteristics
1
2015
790
0.070
 Why?
Mycobacterium tuberculosis
1
2012
334
0.070
 Why?
Aged
5
2018
25913
0.070
 Why?
Lamivudine
2
2023
65
0.070
 Why?
Time Factors
4
2016
7173
0.070
 Why?
Rosuvastatin Calcium
1
2008
21
0.070
 Why?
Logistic Models
2
2026
2117
0.070
 Why?
Child
5
2026
22633
0.070
 Why?
Immunosuppressive Agents
1
2012
846
0.060
 Why?
Pregnancy
4
2025
7190
0.060
 Why?
Gene Frequency
1
2008
481
0.060
 Why?
Portugal
1
2006
10
0.060
 Why?
Kidney Calculi
1
2007
45
0.060
 Why?
Quebec
1
2006
10
0.060
 Why?
Education, Medical
1
2009
274
0.060
 Why?
Self Report
2
2021
872
0.060
 Why?
Observational Studies as Topic
1
2026
129
0.060
 Why?
Internationality
1
2006
156
0.060
 Why?
Dementia
1
2009
303
0.050
 Why?
Hematocrit
2
2016
108
0.050
 Why?
Referral and Consultation
1
2011
851
0.050
 Why?
Sexual and Gender Minorities
2
2019
251
0.050
 Why?
United States
4
2017
15966
0.050
 Why?
Predictive Value of Tests
2
2019
2115
0.050
 Why?
Postpartum Period
1
2026
365
0.050
 Why?
Isoindoles
1
2022
5
0.050
 Why?
Lipids
1
2008
710
0.050
 Why?
Monkeypox virus
1
2022
23
0.050
 Why?
Risk Assessment
1
2012
3671
0.050
 Why?
Calibration
2
2013
151
0.040
 Why?
RNA, Viral
1
2026
688
0.040
 Why?
Demography
1
2022
288
0.040
 Why?
Treatment Failure
1
2023
365
0.040
 Why?
Benzamides
1
2022
224
0.040
 Why?
Infant, Newborn
2
2026
6429
0.040
 Why?
Computer Simulation
2
2016
1025
0.040
 Why?
Temperature
2
2016
679
0.040
 Why?
Animals
4
2022
38058
0.040
 Why?
Drug Approval
1
2020
89
0.040
 Why?
Tissue Donors
1
2023
424
0.040
 Why?
Dose-Response Relationship, Drug
2
2016
2027
0.040
 Why?
Lactation
1
2020
192
0.040
 Why?
Models, Biological
2
2016
1821
0.040
 Why?
Developing Countries
1
2020
318
0.030
 Why?
Chemistry Techniques, Analytical
1
2018
20
0.030
 Why?
Flaviviridae
1
2017
10
0.030
 Why?
Inhibitory Concentration 50
1
2017
91
0.030
 Why?
Vero Cells
1
2017
84
0.030
 Why?
A549 Cells
1
2017
75
0.030
 Why?
Hair
1
2018
88
0.030
 Why?
Drug Repositioning
1
2017
41
0.030
 Why?
Body Mass Index
1
2026
2438
0.030
 Why?
Pharmaceutical Solutions
1
2016
14
0.030
 Why?
Chromatography, Reverse-Phase
1
2016
27
0.030
 Why?
Breast Feeding
1
2020
448
0.030
 Why?
Drug Storage
1
2016
53
0.030
 Why?
Defective Viruses
1
2016
5
0.030
 Why?
Patient Selection
1
2020
719
0.030
 Why?
Cities
1
2017
143
0.030
 Why?
Acute Disease
1
2019
1030
0.030
 Why?
Solubility
1
2016
242
0.030
 Why?
Drug Compounding
1
2016
107
0.030
 Why?
Alcohol Drinking
1
2023
826
0.030
 Why?
Methanol
1
2016
46
0.030
 Why?
Spermatozoa
1
2016
109
0.030
 Why?
Solutions
1
2016
166
0.030
 Why?
Clinical Trials as Topic
1
2020
1053
0.030
 Why?
Hydrogen-Ion Concentration
1
2016
561
0.030
 Why?
Administration, Inhalation
1
2016
574
0.030
 Why?
Cold Temperature
1
2016
209
0.030
 Why?
Blood-Brain Barrier
1
2016
155
0.030
 Why?
Risk-Taking
1
2017
328
0.030
 Why?
Comorbidity
1
2019
1658
0.030
 Why?
Interleukins
1
2016
248
0.030
 Why?
Pregnancy Complications
1
2020
592
0.030
 Why?
DNA, Viral
1
2016
358
0.030
 Why?
Vitamin D-Binding Protein
1
2013
15
0.030
 Why?
Recurrence
1
2017
1135
0.030
 Why?
Feasibility Studies
1
2017
1095
0.020
 Why?
Parathyroid Hormone
1
2013
112
0.020
 Why?
Mental Health
1
2019
790
0.020
 Why?
Algorithms
1
2020
1837
0.020
 Why?
Water
1
2016
469
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
257
0.020
 Why?
Therapeutic Equivalency
1
2012
31
0.020
 Why?
Alkynes
1
2012
66
0.020
 Why?
Cell Line
1
2017
2882
0.020
 Why?
Anion Exchange Resins
1
2011
8
0.020
 Why?
Zidovudine
1
2011
77
0.020
 Why?
Food-Drug Interactions
1
2010
11
0.020
 Why?
Reference Standards
1
2011
177
0.020
 Why?
Chemoprevention
1
2010
90
0.020
 Why?
Latent Tuberculosis
1
2011
71
0.020
 Why?
Longitudinal Studies
1
2018
2947
0.020
 Why?
Haplotypes
1
2011
490
0.020
 Why?
Epithelial Cells
1
2016
1125
0.020
 Why?
Cholesterol
1
2011
406
0.020
 Why?
Glomerular Filtration Rate
1
2013
760
0.020
 Why?
Triglycerides
1
2011
520
0.020
 Why?
AIDS Dementia Complex
1
2009
52
0.020
 Why?
Polymorphism, Genetic
1
2011
612
0.020
 Why?
Follow-Up Studies
1
2017
5408
0.020
 Why?
Acquired Immunodeficiency Syndrome
1
2009
235
0.020
 Why?
Cross-Sectional Studies
1
2019
5868
0.020
 Why?
Positron-Emission Tomography
1
2009
323
0.020
 Why?
Antiemetics
1
1987
49
0.020
 Why?
Calcium
1
2013
1183
0.020
 Why?
Vomiting
1
1987
130
0.020
 Why?
Gene Expression Regulation
1
2016
2608
0.020
 Why?
Aged, 80 and over
1
2018
8265
0.010
 Why?
Neuropsychological Tests
1
2009
1134
0.010
 Why?
Brain
1
2016
2933
0.010
 Why?
Age Factors
1
2011
3333
0.010
 Why?
Alzheimer Disease
1
2009
621
0.010
 Why?
Magnetic Resonance Imaging
1
2009
3863
0.010
 Why?
Antineoplastic Agents
1
1987
2194
0.010
 Why?
Flunitrazepam
1
1987
3
0.000
 Why?
Metoclopramide
1
1987
19
0.000
 Why?
Methylprednisolone
1
1987
64
0.000
 Why?
Kiser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (362) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)